skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: Springer Nature - Springer Journals All 2022 remover idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

Miles, David ; Baselga, José ; Amadori, Dino ; Sunpaweravong, Patrapim ; Semiglazov, Vladimir ; Knott, Adam ; Clark, Emma ; Ross, Graham ; Swain, Sandra M.

Breast cancer research and treatment, 2013-11, Vol.142 (1), p.89-99 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
2
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer

Cristofanilli, Massimo ; Johnston, Stephen R. D. ; Manikhas, Alexey ; Gomez, Henry L. ; Gladkov, Oleg ; Shao, Zhimin ; Safina, Sufia ; Blackwell, Kimberly L. ; Alvarez, Ricardo H. ; Rubin, Stephen D. ; Ranganathan, Sulabha ; Redhu, Suman ; Trudeau, Maureen E.

Breast cancer research and treatment, 2013, Vol.137 (2), p.471-482 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
3
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

Pienta, Kenneth J. ; Machiels, Jean-Pascal ; Schrijvers, Dirk ; Alekseev, Boris ; Shkolnik, Mikhail ; Crabb, Simon J. ; Li, Susan ; Seetharam, Shobha ; Puchalski, Thomas A. ; Takimoto, Chris ; Elsayed, Yusri ; Dawkins, Fitzroy ; de Bono, Johann S.

Investigational new drugs, 2013-06, Vol.31 (3), p.760-768 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
4
Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations
Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations

Prokofyeva, Darya ; Bogdanova, Natalia ; Dubrowinskaja, Natalia ; Bermisheva, Marina ; Takhirova, Zalina ; Antonenkova, Natalia ; Turmanov, Nurzhan ; Datsyuk, Ihor ; Gantsev, Shamil ; Christiansen, Hans ; Park-Simon, Tjoung-Won ; Hillemanns, Peter ; Khusnutdinova, Elza ; Dörk, Thilo

Breast cancer research and treatment, 2013-01, Vol.137 (2), p.533-539 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
5
miR-485-3p and miR-4728-5p as Tumor Suppressors in Pathogenesis of Colorectal Cancer
miR-485-3p and miR-4728-5p as Tumor Suppressors in Pathogenesis of Colorectal Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

miR-485-3p and miR-4728-5p as Tumor Suppressors in Pathogenesis of Colorectal Cancer

Gurer, T. ; Aytekin, A. ; Caki, E. ; Gezici, S.

Molecular biology (New York), 2022-06, Vol.56 (3), p.474-488 [Periódico revisado por pares]

Moscow: Pleiades Publishing

Texto completo disponível

Citações Citado por
6
OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model
OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model
Material Type:
Artigo 		Adicionar ao Meu Espaço

OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model

Tsimafeyeu, Ilya ; Zaveleva, Elina ; Stepanova, Evgenia ; Low, Walter

Investigational new drugs, 2013-12, Vol.31 (6), p.1436-1443 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
7
Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells

Berstein, Lev M. ; Yue, Wei ; Wang, Ji-Ping ; Santen, Richard J.

Breast cancer research and treatment, 2011-07, Vol.128 (1), p.109-117 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
8
Mapping Regulatory Elements within 5' and 3' UTRs of SIGLEC15 with a Use of Reporter System
Mapping Regulatory Elements within 5' and 3' UTRs of SIGLEC15 with a Use of Reporter System
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mapping Regulatory Elements within 5' and 3' UTRs of SIGLEC15 with a Use of Reporter System

Wang, L. ; Li, R. ; Lai, X. ; Zhang, X. ; Chen, H. ; Zhao, W.

Molecular biology (New York), 2022-06, Vol.56 (3), p.406-416 [Periódico revisado por pares]

Moscow: Pleiades Publishing

Texto completo disponível

Citações Citado por
9
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy

Johnston, Stephen R. D. ; Semiglazov, Vladimir F. ; Manikhas, George M. ; Spaeth, Dominique ; Romieu, Gilles ; Dodwell, David J. ; Wardley, Andrew M. ; Neven, Patrick ; Bessems, Annick ; Park, Youn C. ; De Porre, Peter M. ; Perez Ruixo, Juan J. ; Howes, Angela J.

Breast cancer research and treatment, 2008-07, Vol.110 (2), p.327-335 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
10
Epidermal Growth Factor Mediates Up-Regulation of URGCP Oncogene in Human Hepatoma Cancer Cells
Epidermal Growth Factor Mediates Up-Regulation of URGCP Oncogene in Human Hepatoma Cancer Cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Epidermal Growth Factor Mediates Up-Regulation of URGCP Oncogene in Human Hepatoma Cancer Cells

Tokay, E.

Molecular biology (New York), 2021-07, Vol.55 (4), p.618-623 [Periódico revisado por pares]

Moscow: Pleiades Publishing

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2005  (8)
  2. 2005Até2008  (27)
  3. 2009Até2012  (36)
  4. 2013Até2017  (23)
  5. Após 2017  (12)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.